Opportunity Information: Apply for PAR 12 287
Apply for PAR 12 287
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Advanced Development of Informatics Technology (U24)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.396 Cancer Biology Research.
- This funding opportunity was created on Aug 6, 2013 and posted on Sep 19, 2012.
- Applicants must submit their applications by Aug 6, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Public housing authorities/Indian housing authorities Private institutions of higher education Independent school districts City or township governments County governments Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Small businesses State governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Advanced Development of Informatics Technology (U24) funding opportunity (PAR-12-287) is a National Institutes of Health program, led through the National Cancer Institute, aimed at pushing promising cancer-focused informatics tools beyond the early prototype stage and into more mature, impactful, and broadly usable technologies. The core idea is to support advanced development and enhancement of "emerging" informatics technologies that can meaningfully improve how cancer research data and knowledge are acquired, managed, analyzed, and shared. These projects are expected to strengthen real-world usability, scalability, performance, robustness, and adoption potential, rather than simply proving a concept.
A key feature of this FOA is how it defines an "emerging informatics technology." The technology should already be past initial prototyping and pilot development, with enough evidence to show it could have significant broader impact. At the same time, it should still have clear reasons why additional development is needed, and it should not yet be widely adopted in the cancer research community. In other words, the announcement is targeting tools that are promising but not finished: they have shown value, but they need substantial engineering, refinement, and enhancement to become widely usable and to influence cancer research at scale.
The program is designed to accelerate progress across multiple areas of cancer research, including cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and research addressing cancer health disparities. By improving the underlying informatics infrastructure and tools used in these domains, the FOA aims to make research workflows more efficient, reproducible, and collaborative. Technologies funded under this mechanism are expected to enable better handling of complex cancer datasets and better dissemination of resulting knowledge to researchers and, indirectly, to clinicians and public health communities.
This opportunity uses the Cooperative Agreement (U24) funding instrument, which typically implies substantial involvement from the funding agency compared with a standard research grant. Practically, that usually means funded teams should be prepared for an interactive relationship with NCI program staff, including coordination, milestone-driven development expectations, and alignment with broader initiative goals. The FOA is explicitly positioned as part of the NCI Informatics Technology for Cancer Research (ITCR) Initiative, which focuses on research-driven informatics technology development and seeks to build a portfolio of interoperable, high-impact tools for the cancer research ecosystem.
The FOA also draws a firm boundary around what does not fit. Applications that primarily focus on data processing and analysis or on mathematical/statistical modeling, without true informatics technology development, are considered non-responsive. The emphasis is on creating or substantially advancing a technology platform, tool, or system, not simply applying existing tools to analyze datasets or developing methods in isolation from a software or systems deliverable. Applicants interested in earlier, more exploratory work are directed to companion FOAs tailored for early-stage development, signaling that this particular announcement is meant for projects ready for a more advanced build and broader dissemination pathway.
From an administrative standpoint, the opportunity is categorized as discretionary funding under the health activity area and is associated with CFDA number 93.396 (Cancer Biology Research). It does not require cost sharing or matching. The listed award ceiling is $500,000, indicating an upper bound on annual direct costs or total costs depending on NIH-specific interpretation in the full announcement; applicants would need to confirm the budget structure details in the NIH guide notice itself. Key dates shown in the source record include a posted date of September 19, 2012, with the record later created on August 6, 2013, and an original closing date of June 18, 2015; the dataset excerpt also shows a "current closing date" of August 6, 2013 and an archive date of September 6, 2013, suggesting the listing snapshot reflects an archived or time-bounded version of the opportunity and that applicants would need to verify the currently active status through NIH systems if looking for a live equivalent today.
Eligibility is broad and includes many organization types: for-profit organizations (including those other than small businesses), small businesses, nonprofits (both 501(c)(3) and non-501(c)(3)), public and private institutions of higher education, and a wide range of government entities (state, county, city or township, special district). It also includes Native American tribal governments (both federally recognized and other than federally recognized) and tribal organizations, public housing authorities/Indian housing authorities, independent school districts, and additional categories such as faith-based or community-based organizations. The eligibility list explicitly includes minority-serving institutions such as HBCUs, Hispanic-serving institutions, AANAPISIs, Alaska Native and Native Hawaiian serving institutions, and tribally controlled colleges and universities. Notably, the FOA also indicates eligibility for non-domestic (non-U.S.) entities (foreign organizations), as well as regional organizations and U.S. territories or possessions, which is important for international collaborations and multi-region informatics efforts.
Overall, PAR-12-287 is best understood as a later-stage technology maturation opportunity within NCI's ITCR program: it is intended for teams that already have an informatics technology with demonstrated promise and are ready to harden it, expand its capabilities, and move it toward broader adoption in cancer research. The strongest fit would be projects where the main outputs are improved software, platforms, standards-based tools, or other informatics technologies that measurably enhance how cancer research data and knowledge are handled, shared, and reused across the community.
FAQs: Advanced Development of Informatics Technology (U24) - PAR-12-287
What is PAR-12-287 (Advanced Development of Informatics Technology - U24)?
PAR-12-287 is a National Institutes of Health (NIH) funding opportunity, led through the National Cancer Institute (NCI), that supports the advanced development of cancer-focused informatics technologies. The goal is to move promising tools beyond early prototypes into more mature, broadly usable, and higher-impact technologies for the cancer research community.
What is the main purpose of this funding opportunity?
The purpose is to fund advanced development and enhancement of emerging informatics technologies that can improve how cancer research data and knowledge are acquired, managed, analyzed, and shared. Projects are expected to strengthen real-world usability, scalability, performance, robustness, and adoption potential, rather than simply proving a concept.
What kinds of projects are a strong fit for this FOA?
The strongest fit is a project where the main outputs are improved software, platforms, standards-based tools, or other informatics technologies that measurably enhance how cancer research data and knowledge are handled, shared, and reused across the community.
What does the FOA mean by an "emerging informatics technology"?
In this FOA, an emerging informatics technology is one that is already past initial prototyping and pilot development and has enough evidence to suggest it could have significant broader impact. At the same time, it still needs additional development and is not yet widely adopted in the cancer research community.
Is this opportunity meant for early-stage prototypes or exploratory work?
No. This announcement targets tools that have already demonstrated promise beyond early prototyping but still require substantial engineering, refinement, and enhancement to become widely usable and to influence cancer research at scale. Earlier and more exploratory work is directed to companion FOAs designed for early-stage development.
What is the expected emphasis of funded work?
The emphasis is on advanced technology maturation: improving usability, scalability, performance, robustness, and the potential for broad adoption. The expectation is that the technology will be strengthened for real-world use and broader dissemination rather than remaining a limited pilot or proof of concept.
What research areas can these informatics technologies support?
The FOA is designed to accelerate progress across multiple areas of cancer research, including cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and research addressing cancer health disparities.
How does this FOA relate to the NCI Informatics Technology for Cancer Research (ITCR) Initiative?
This FOA is explicitly positioned as part of NCI's Informatics Technology for Cancer Research (ITCR) Initiative. ITCR focuses on research-driven informatics technology development and aims to build a portfolio of interoperable, high-impact tools for the cancer research ecosystem.
What does it mean that this is a Cooperative Agreement (U24)?
A Cooperative Agreement (U24) typically implies substantial involvement from the funding agency compared with a standard research grant. In practice, funded teams should be prepared for an interactive relationship with NCI program staff, including coordination, milestone-driven development expectations, and alignment with broader initiative goals.
Are applications focused mainly on data analysis or statistical modeling responsive to this FOA?
No. Applications that primarily focus on data processing and analysis or on mathematical/statistical modeling, without true informatics technology development, are considered non-responsive. The FOA emphasizes creating or substantially advancing a technology platform, tool, or system rather than applying existing tools to analyze datasets or developing methods without a software/systems deliverable.
What types of deliverables are implied by the FOA's focus?
The FOA emphasizes tangible informatics technology outputs such as software, platforms, toolkits, or systems-level deliverables that can be strengthened for broader usability and dissemination within the cancer research community.
What is the maximum award amount mentioned in the listing?
The listing shows an award ceiling of $500,000. The description notes this may represent an upper bound on annual direct costs or total costs depending on NIH interpretation in the full announcement, so applicants would need to confirm the budget structure details in the NIH guide notice itself.
Is cost sharing or matching required?
No. The opportunity does not require cost sharing or matching.
What is the CFDA number and activity area associated with this opportunity?
The opportunity is associated with CFDA number 93.396 (Cancer Biology Research) and is categorized as discretionary funding under the health activity area.
Who is eligible to apply?
Eligibility is broad and includes for-profit organizations (including those other than small businesses), small businesses, nonprofits (both 501(c)(3) and non-501(c)(3)), public and private institutions of higher education, and a wide range of government entities (state, county, city or township, and special district).
Are tribal governments and tribal organizations eligible?
Yes. The eligibility list includes Native American tribal governments (both federally recognized and other than federally recognized) and tribal organizations.
Are public housing authorities, school districts, or community-based organizations eligible?
Yes. The eligibility list includes public housing authorities/Indian housing authorities, independent school districts, and categories such as faith-based or community-based organizations.
Are minority-serving institutions specifically included in the eligibility list?
Yes. The eligibility list explicitly includes minority-serving institutions such as HBCUs, Hispanic-serving institutions, AANAPISIs, Alaska Native and Native Hawaiian serving institutions, and tribally controlled colleges and universities.
Can foreign (non-U.S.) organizations apply?
Yes. The FOA indicates eligibility for non-domestic (non-U.S.) entities (foreign organizations). It also includes regional organizations and U.S. territories or possessions.
What are the key dates shown for this opportunity?
The source record includes a posted date of September 19, 2012, a record created date of August 6, 2013, an original closing date of June 18, 2015, a "current closing date" of August 6, 2013, and an archive date of September 6, 2013.
Is this listing potentially archived or time-bounded?
Yes. The presence of an archive date and conflicting closing date fields in the dataset excerpt suggests the listing snapshot reflects an archived or time-bounded version of the opportunity. Anyone looking for a live equivalent would need to verify the currently active status through NIH systems.
What is the overall "best use case" summary for PAR-12-287?
PAR-12-287 is best understood as a later-stage technology maturation opportunity within NCI's ITCR program. It is intended for teams that already have an informatics technology with demonstrated promise and are ready to harden it, expand its capabilities, and move it toward broader adoption in cancer research.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Early Stage Development of Informatics Technology (U01)
Previous opportunity: Revisions for Early Stage Development of Informatics Technology (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 12 287
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 12 287) also looked into and applied for these:
| Funding Opportunity |
|---|
| Early Stage Development of Informatics Technology (U01) Apply for PAR 12 288 Funding Number: PAR 12 288 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Revisions for Early Stage Development of Informatics Technology (U01) Apply for PAR 12 289 Funding Number: PAR 12 289 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Revisions for Early Stage Development of Informatics Technology (P01) Apply for PAR 12 290 Funding Number: PAR 12 290 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Research Answers to NCIs Provocative Questions Group A (R01) Apply for RFA CA 12 015 Funding Number: RFA CA 12 015 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions Group A (R21) Apply for RFA CA 12 016 Funding Number: RFA CA 12 016 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research Answers to NCIs Provocative Questions Group B (R01) Apply for RFA CA 12 017 Funding Number: RFA CA 12 017 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions Group B (R21) Apply for RFA CA 12 018 Funding Number: RFA CA 12 018 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research Answers to NCIs Provocative Questions Group C (R01) Apply for RFA CA 12 019 Funding Number: RFA CA 12 019 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions Group C (R21) Apply for RFA CA 12 020 Funding Number: RFA CA 12 020 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research Answers to NCIs Provocative Questions Group D (R01) Apply for RFA CA 12 021 Funding Number: RFA CA 12 021 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions Group D (R21) Apply for RFA CA 12 022 Funding Number: RFA CA 12 022 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Years 2013 and 2014 (P50) Apply for PAR 12 296 Funding Number: PAR 12 296 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Drug Abuse Aspects of HIV/AIDS (R01) Apply for PA 12 293 Funding Number: PA 12 293 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Drug Abuse Aspects of HIV/AIDS (R03) Apply for PA 12 294 Funding Number: PA 12 294 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Drug Abuse Aspects of HIV/AIDS (R21) Apply for PA 12 295 Funding Number: PA 12 295 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Mechanism for Time Sensitive Drug Abuse Research (R21) Apply for PAR 12 297 Funding Number: PAR 12 297 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Cancer Center Support Grants (CCSGs) for NCI designated Cancer Centers (P30) Apply for PAR 12 298 Funding Number: PAR 12 298 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| FY 2013 American Schools and Hospitals Abroad (ASHA) Program Worldwide Apply for APS ASHA 13 000001 Funding Number: APS ASHA 13 000001 Agency: Agency for International Development Category: Education Health Funding Amount: $2,000,000 |
| NLM Grants for Scholarly Works in Biomedicine and Health (G13) Apply for PAR 13 014 Funding Number: PAR 13 014 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Prescription Drug Abuse (R01) Apply for PA 13 015 Funding Number: PA 13 015 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 12 287", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
